Display options
Cite
Bihl FK, Loggi E, Chisholm JV, et al. Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot". J Transl Med. 2005;3(1):20doi: 10.1186/1479-5876-3-20.
Bihl, F. K., Loggi, E., Chisholm, J. V., Hewitt, H. S., Henry, L. M., Linde, C., Suscovich, T. J., Wong, J. T., Frahm, N., Andreone, P., & Brander, C. (2005). Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot". Journal of translational medicine, 3(1), 20. https://doi.org/10.1186/1479-5876-3-20
Bihl, Florian K, et al. "Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot"." Journal of translational medicine vol. 3,1 (2005): 20. doi: https://doi.org/10.1186/1479-5876-3-20
Bihl FK, Loggi E, Chisholm JV, Hewitt HS, Henry LM, Linde C, Suscovich TJ, Wong JT, Frahm N, Andreone P, Brander C. Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot". J Transl Med. 2005 May 11;3(1):20. doi: 10.1186/1479-5876-3-20. PMID: 15888204; PMCID: PMC1164435.
Copy Download .nbib Format: NLM
Share it on

J Transl Med. 2005 May 11;3(1):20. doi: 10.1186/1479-5876-3-20.

Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot".

Journal of translational medicine

Florian K Bihl, Elisabetta Loggi, John V Chisholm, Hannah S Hewitt, Leah M Henry, Caitlyn Linde, Todd J Suscovich, Johnson T Wong, Nicole Frahm, Pietro Andreone, Christian Brander

Affiliations

  1. Partners AIDS Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, USA. [email protected].

PMID: 15888204 PMCID: PMC1164435 DOI: 10.1186/1479-5876-3-20

Abstract

The assessment of cellular anti-viral immunity is often hampered by the limited availability of adequate samples, especially when attempting simultaneous, high-resolution determination of T cell responses against multiple viral infections. Thus, the development of assay systems, which optimize cell usage, while still allowing for the detailed determination of breadth and magnitude of virus-specific cytotoxic T lymphocyte (CTL) responses, is urgently needed. This study provides an up-to-date listing of currently known, well-defined viral CTL epitopes for HIV, EBV, CMV, HCV and HBV and describes an approach that overcomes some of the above limitations through the use of peptide matrices of optimally defined viral CTL epitopes in combination with anti-CD3 in vitro T cell expansion and re-use of cells from negative ELISpot wells. The data show that, when compared to direct ex vivo cell preparations, antigen-unspecific in vitro T cell expansion maintains the breadth of detectable T cell responses and demonstrates that harvesting cells from negative ELISpot wells for re-use in subsequent ELISpot assays (RecycleSpot), further maximized the use of available cells. Furthermore when combining T cell expansion and RecycleSpot with the use of rationally designed peptide matrices, antiviral immunity against more than 400 different CTL epitopes from five different viruses can be reproducibly assessed from samples of less than 10 milliliters of blood without compromising information on the breadth and magnitude of these responses. Together, these data support an approach that facilitates the assessment of cellular immunity against multiple viral co-infections in settings where sample availability is severely limited.

References

  1. J Exp Med. 2000 May 1;191(9):1499-512 - PubMed
  2. J Immunol. 1998 Feb 1;160(3):1479-88 - PubMed
  3. J Immunol. 1993 Oct 15;151(8):3971-80 - PubMed
  4. J Virol. 2004 Mar;78(5):2187-200 - PubMed
  5. J Immunol Methods. 2004 May;288(1-2):135-47 - PubMed
  6. J Infect Dis. 1995 Jul;172(1):88-96 - PubMed
  7. Blood. 2001 Sep 15;98(6):1872-81 - PubMed
  8. J Virol. 2002 Jun;76(12):6104-13 - PubMed
  9. J Immunol. 2000 Dec 15;165(12):7078-87 - PubMed
  10. Viral Immunol. 2001;14(4):369-77 - PubMed
  11. Eur J Immunol. 1999 Sep;29(9):2908-15 - PubMed
  12. J Exp Med. 1992 Jul 1;176(1):169-76 - PubMed
  13. J Immunol. 1993 May 15;150(10):4659-71 - PubMed
  14. Yonsei Med J. 2004 Jun 30;45 Suppl:18-22 - PubMed
  15. J Exp Med. 1995 Jun 1;181(6):2221-8 - PubMed
  16. Annu Rev Immunol. 1997;15:405-31 - PubMed
  17. J Gen Virol. 1998 Jul;79 ( Pt 7):1735-44 - PubMed
  18. J Clin Invest. 1998 Jun 1;101(11):2559-66 - PubMed
  19. Hepatology. 1993 Nov;18(5):1039-44 - PubMed
  20. J Exp Med. 1997 May 5;185(9):1605-17 - PubMed
  21. J Virol. 1993 Dec;67(12):7522-32 - PubMed
  22. Eur J Immunol. 1995 Jan;25(1):18-24 - PubMed
  23. Hepatology. 1999 Sep;30(3):595-601 - PubMed
  24. J Immunol. 1991 Apr 15;146(8):2795-804 - PubMed
  25. Annu Rev Microbiol. 2000;54:19-48 - PubMed
  26. J Infect Dis. 2001 Jul 15;184(2):119-26 - PubMed
  27. J Infect Dis. 2002 Jun 15;185(12):1709-16 - PubMed
  28. Transplantation. 1990 Oct;50(4):683-9 - PubMed
  29. J Virol. 1993 Apr;67(4):2376-80 - PubMed
  30. Blood. 2003 Feb 15;101(4):1460-8 - PubMed
  31. J Med Virol. 2003 May;70(1):51-61 - PubMed
  32. J Med Virol. 2002 Jul;67(3):359-63 - PubMed
  33. J Virol. 2000 Feb;74(4):1801-9 - PubMed
  34. Blood. 2004 Jul 15;104(2):487-94 - PubMed
  35. J Immunol. 1995 Mar 15;154(6):2733-42 - PubMed
  36. J Virol. 1990 Aug;64(8):3974-6 - PubMed
  37. J Virol. 2001 Feb;75(3):1229-35 - PubMed
  38. J Hepatol. 2001 Jun;34(6):922-9 - PubMed
  39. Curr Opin Immunol. 1999 Aug;11(4):451-9 - PubMed
  40. J Immunol. 2000 Jul 1;165(1):573-82 - PubMed
  41. J Virol. 1996 Aug;70(8):5357-62 - PubMed
  42. J Immunol. 2003 Mar 1;170(5):2590-8 - PubMed
  43. J Infect Dis. 2005 Nov 1;192(9):1513-24 - PubMed
  44. J Virol. 1996 Jan;70(1):232-40 - PubMed
  45. J Virol. 2000 May;74(9):3948-52 - PubMed
  46. J Immunol. 1998 Nov 15;161(10):5252-9 - PubMed
  47. J Immunol. 1994 Dec 15;153(12):5586-92 - PubMed
  48. J Clin Invest. 1995 Nov;96(5):2311-21 - PubMed
  49. J Immunol. 1992 Nov 15;149(10):3339-44 - PubMed
  50. J Virol. 1996 Apr;70(4):2394-402 - PubMed
  51. Blood. 2004 Jan 15;103(2):630-8 - PubMed
  52. J Exp Med. 1993 Mar 1;177(3):751-62 - PubMed
  53. Virus Res. 1997 Aug;50(2):185-94 - PubMed
  54. J Immunother (1991). 1992 Oct;12(3):180-2 - PubMed
  55. J Virol. 1993 Dec;67(12):7428-35 - PubMed
  56. Antiviral Res. 2003 Oct;60(2):61-6 - PubMed
  57. Gastroenterology. 2004 Sep;127(3):924-36 - PubMed
  58. Hepatology. 2001 Jun;33(6):1533-43 - PubMed
  59. J Clin Invest. 1995 Sep;96(3):1527-34 - PubMed
  60. J Virol. 1994 May;68(5):3334-42 - PubMed
  61. J Virol. 1998 Nov;72(11):8644-9 - PubMed
  62. J Virol. 1996 Nov;70(11):7569-79 - PubMed
  63. J Immunol Methods. 2003 Mar 1;274(1-2):139-47 - PubMed
  64. J Immunol. 2001 Aug 15;167(4):2019-29 - PubMed
  65. J Virol. 1998 Aug;72(8):6614-20 - PubMed
  66. J Clin Invest. 1995 Feb;95(2):521-30 - PubMed
  67. Immunogenetics. 2001;52(3-4):165-73 - PubMed
  68. Vaccine. 2002 Nov 1;20(31-32):3770-7 - PubMed
  69. Vaccine. 2001 Jun 14;19(27):3769-77 - PubMed
  70. Int J Cancer. 2002 May 1;99(1):93-9 - PubMed
  71. J Virol. 2005 Apr;79(7):4289-97 - PubMed
  72. J Virol. 2003 Feb;77(3):2081-92 - PubMed
  73. J Exp Med. 1996 Nov 1;184(5):1801-13 - PubMed
  74. J Immunol Methods. 2003 Aug;279(1-2):17-31 - PubMed
  75. J Exp Med. 1993 Sep 1;178(3):879-87 - PubMed
  76. J Immunol. 1997 Aug 15;159(4):1844-52 - PubMed
  77. J Med Virol. 2004 Nov;74(3):397-405 - PubMed
  78. J Virol. 2003 Feb;77(4):2757-61 - PubMed
  79. Eur J Immunol. 1998 Feb;28(2):451-8 - PubMed
  80. J Immunol. 1997 Apr 1;158(7):3325-34 - PubMed
  81. J Hepatol. 2001 Feb;34(2):321-9 - PubMed
  82. J Virol. 1995 Apr;69(4):2462-70 - PubMed
  83. J Gen Virol. 1994 Sep;75 ( Pt 9):2489-93 - PubMed
  84. J Exp Med. 1995 Mar 1;181(3):1047-58 - PubMed
  85. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9478-82 - PubMed
  86. J Virol. 1996 Dec;70(12):8858-64 - PubMed
  87. J Gen Virol. 1996 Jun;77 ( Pt 6):1305-9 - PubMed
  88. Gut. 2005 Jan;54(1):152-61 - PubMed
  89. J Immunol. 1999 Nov 15;163(10):5512-8 - PubMed

Publication Types

Grant support